ATI RN
ATI Pharmacology 2023 III Questions
Question 1 of 5
A nurse is caring for a client who has cirrhosis of the liver and is receiving spironolactone. Which of the following findings indicates that the client is responding to the treatment?
Correct Answer: C
Rationale: The correct answer is C: Decreased ascites. Spironolactone, a potassium-sparing diuretic, is commonly used in cirrhotic patients to decrease fluid retention and ascites. As the medication helps to increase urine output and reduce fluid accumulation in the abdomen, a decrease in ascites would indicate that the client is responding positively to the treatment. Increased energy (choice
A) and increased appetite (choice
D) are not direct indicators of the medication's effectiveness in treating cirrhotic ascites. Decreased jaundice (choice
B) may improve with liver function but is not a specific response to spironolactone.
Question 2 of 5
A nurse is planning care for a group of clients. Which of the following client's medications should be monitored by the nurse for hearing loss related to a medication interaction?
Correct Answer: C
Rationale: The correct answer is C: Furosemide and amikacin. Furosemide is a loop diuretic known to cause ototoxicity, including hearing loss. Amikacin is an aminoglycoside antibiotic also associated with ototoxicity. When combined, they can potentiate each other's ototoxic effects, increasing the risk of hearing loss. Monitoring for any signs of hearing impairment is crucial.
Incorrect choices:
A: Propranolol and raloxifene - These medications are not known to cause hearing loss.
B: Losartan and atorvastatin - These medications are not associated with hearing loss.
D: Digoxin and levothyroxine - These medications are not typically linked to hearing loss.
Question 3 of 5
A nurse is assessing a client with hypertension who is receiving propranolol. Which of the following findings requires the nurse's intervention?
Correct Answer: A
Rationale: The correct answer is A because propranolol is a beta-blocker that can slow down the heart rate. A heart rate of 56/min may indicate bradycardia, which can be a sign of overdose or adverse reaction to the medication. The nurse should intervene by assessing for symptoms of bradycardia and potentially contacting the healthcare provider.
Choices B, C, and D are within normal ranges and do not require immediate intervention.
Choice B indicates adequate oxygen saturation, choice C shows normal respiratory rate, and choice D represents a slightly low but acceptable blood pressure reading.
Question 4 of 5
A nurse is caring for a client who has a prescription for nifedipine. Which of the following findings should the nurse assess prior to administration of the medication?
Correct Answer: A
Rationale: The correct answer is A: Blood pressure. Nifedipine is a calcium channel blocker used to treat hypertension. Monitoring the client's blood pressure prior to administration is crucial as nifedipine can cause significant hypotension. Assessing respiratory rate, temperature, and oxygen saturation are important but not specific to nifedipine administration. Blood pressure is the most relevant parameter to monitor for this medication.
Question 5 of 5
A nurse is developing a teaching plan for an older adult client who has a new prescription for insulin glargine. Which of the following expected outcomes should the nurse include in the plan?
Correct Answer: D
Rationale:
Correct
Answer: D
Rationale:
1. Safety: Wearing reading glasses ensures accurate dosage measurement, crucial for insulin administration.
2. Precision: Insulin dosage is precise; reading glasses help ensure correct measurement.
3. Client-centered: Older adults may have visual impairments; wearing glasses promotes self-care.
4. Education: Teaches importance of accuracy in insulin administration to prevent complications.
Summary:
A: Incorrect - Insulin glargine is a long-acting insulin and is not necessarily administered before each meal.
B: Incorrect - Deltoid muscle is not a recommended site for insulin injections due to variable absorption rates.
C: Incorrect - Additional doses of insulin glargine should be prescribed by a healthcare provider, not based on exercise alone.